Pathfinder Cell Therapy, Revenue Growth Rates (PFND), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Pathfinder Cell Therapy, Inc.  (PFND)
 

PFND's Revenue Growth by Quarter and Year

Pathfinder Cell Therapy,'s Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PFND Revenue (in millions $) FY 2015 FY 2014 FY 2013 FY 2012
4th Quarter December -
3rd Quarter September 0.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 0.00





PFND Revenue third quarter 2015 Y/Y Growth Comment
Pathfinder Cell Therapy, Inc. in the third quarter 2015 recorded of $ 0.00 millions.

According to the results reported in the third quarter 2015, Pathfinder Cell Therapy, Inc. achieved the best Revenue growth in Medical Equipment & Supplies industry. While Pathfinder Cell Therapy, Inc.' s Revenue no change of 0% ranks overall at the positon no. in the third quarter 2015.


PFND Revenue ( Y/Y Growth %) 2015
 2014 2013 2012
4th Quarter December - - - -
3rd Quarter September - - -50 % 100 %
2nd Quarter June - - -33.33 % -72.73 %
1st Quarter March - - 0 % -
FY   - - -54.55 % -

Financial Statements
Pathfinder Cell Therapy,'s third quarter 2015 Revenue $ 0.00 millions PFND's Income Statement
Pathfinder Cell Therapy,'s third quarter 2014 Revenue $ 0.00 millions Quarterly PFND's Income Statement


PFND Revenue (Quarter on Quarter Growth %)

 2015
 2014 2013 2012
4th Quarter December - - - 50 %
3rd Quarter September - - -50 % -33.33 %
2nd Quarter June - - -33.33 % 0 %
1st Quarter March - - 0 % -
FY (Year on Year)   - - -54.55 % -


Back to PFND Growth rate Comparisons >> Back to PFND Growth rate Comparisons >>


Revenue third quarter 2015 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue third quarter 2015 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2012, 2013, 2014, 2015

Pathfinder Cell Therapy,'s Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PFND's III. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PFND's III. Quarter Q/Q Revenue Comment


Pathfinder Cell Therapy,'s 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2015)		 12 Months Ending
(Jun 30 2015)		 12 Months Ending
(Mar 31 2015)		 12 Months Ending
(Dec 31 2014)		 12 Months Ending
(Sep 30 2014)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Sep 30 2015 period, Pathfinder Cell Therapy,'s cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Pathfinder Cell Therapy, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Sep 30 2015 period, Pathfinder Cell Therapy,'s cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Pathfinder Cell Therapy, Inc. achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PFND's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Sep 30 2015 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2015
Intercept Pharmaceuticals inc -0.09%$ -0.091 millions
Rafina Innovations Inc.-0.13%$ -0.131 millions
Phibro Animal Health Corporation-0.18%$ -0.180 millions
Arqule Inc-0.34%$ -0.338 millions
Msa Safety Inc-0.57%$ -0.568 millions
Achaogen, Inc.-0.97%$ -0.973 millions
Quest Diagnostics Inc-1.26%$ -1.261 millions
Nutrastar International Inc.-1.31%$ -1.312 millions
Integra Lifesciences Holdings Corp-1.46%$ -1.459 millions
Cyteir Therapeutics Inc -1.87%$ -1.875 millions
Lantheus Holdings Inc -2.06%$ -2.060 millions
Fonar Corporation-2.08%$ -2.080 millions
Pfizer Inc-2.22%$ -2.217 millions
Endo International Plc-2.38%$ -2.384 millions
American Shared Hospital Services-2.69%$ -2.687 millions
Bio Green Med Solution Inc -2.72%$ -2.721 millions
Ufp Technologies Inc -2.73%$ -2.726 millions
Seaspine Holdings Corporation-2.76%$ -2.758 millions
Natera Inc -2.92%$ -2.924 millions
Igc Pharma Inc -2.94%$ -2.938 millions
Teleflex Incorporated-2.94%$ -2.944 millions
Milestone Scientific Inc -2.96%$ -2.964 millions
West Pharmaceutical Services Inc -3.20%$ -3.203 millions
Conmed Corporation-3.30%$ -3.302 millions
Five Prime Therapeutics Inc -3.32%$ -3.317 millions
Standard Biotools Inc -3.35%$ -3.347 millions
Haemonetics Corporation-3.47%$ -3.466 millions
U s Stem Cell Inc -3.78%$ -3.783 millions
Mettler toledo International Inc -3.97%$ -3.965 millions
Allied Healthcare Products inc -4.32%$ -4.324 millions


About Pathfinder Cell Therapy, Revenue Growth Rates (PFND), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.